According to Heska Corporation
's latest financial reports the company has S$0.15 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | S$0.20 B | -30.53% |
2021-12-31 | S$0.30 B | 164.63% |
2020-12-31 | S$0.11 B | -4.84% |
2019-12-31 | S$0.12 B | 556.2% |
2018-12-31 | S$18.29 M | 41.59% |
2017-12-31 | S$12.91 M | -17.3% |
2016-12-31 | S$15.62 M | 60.29% |
2015-12-31 | S$9.74 M | 25.98% |
2014-12-31 | S$7.73 M | 1.5% |
2013-12-31 | S$7.62 M | 7.76% |
2012-12-31 | S$7.07 M | -13.74% |
2011-12-31 | S$8.2 M | 15.92% |
2010-12-31 | S$7.07 M | -6.68% |
2009-12-31 | S$7.58 M | 12.67% |
2008-12-31 | S$6.72 M | -15.35% |
2007-12-31 | S$7.94 M | -1.73% |
2006-12-31 | S$8.08 M | -7.13% |
2005-12-31 | S$8.7 M | 7.16% |
2004-12-31 | S$8.12 M | -1.91% |
2003-12-31 | S$8.28 M | -20.75% |
2002-12-31 | S$10.45 M | -1.08% |
2001-12-31 | S$10.57 M | 7.79% |
2000-12-31 | S$9.8 M | -75.46% |
1999-12-31 | S$39.96 M | 310.23% |
1998-12-31 | S$9.74 M | -46% |
1997-12-31 | S$18.04 M | 95.31% |
1996-12-31 | S$9.23 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() IDEXX Laboratories IDXX | S$0.20 B | 30.96% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | S$4.10 B | 2,472.26% | ๐บ๐ธ USA |
![]() Petco WOOF | S$0.16 B | 6.50% | ๐บ๐ธ USA |
![]() Pfizer PFE | S$22.07 B | 13,729.68% | ๐บ๐ธ USA |
![]() Merck MRK | S$11.76 B | 7,270.08% | ๐บ๐ธ USA |
![]() Novartis NVS | S$9.17 B | 5,647.19% | ๐จ๐ญ Switzerland |
![]() Zoetis ZTS | S$2.19 B | 1,274.50% | ๐บ๐ธ USA |